Corvus Pharmaceuticals Inc (NASDAQ:CRVS)

3.33
Delayed Data
As of Feb 27
 -0.38 / -10.24%
Today’s Change
2.53
Today|||52-Week Range
8.10
-38.79%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization228.0K180.0K186.0K186.0K
 
 
 
 
 
 
Operating ExpensesGross Income-228.0K-180.0K-186.0K-186.0K
 
 
 
 
 
General Expenses10.9M11.0M12.1M13.4M
 
 
 
 
 
Research And Development8.4M8.4M9.4M10.6M
 
 
 
 
 
Total Operating Expenses11.1M11.2M12.3M13.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-11.1M-11.2M-12.3M-13.6M
 
 
 
 
 
Other Expenses651.0K662.0K662.0K618.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.5M-10.5M-11.6M-13.0M
 
 
 
 
 
Net Income-10.5M-10.5M-11.6M-13.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS29.1M29.2M29.3M29.3M
 
 
 
 
 
Shares To Calculate EPS Diluted29.1M29.2M29.3M29.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.36-$0.36-$0.40-$0.44
 
 
 
 
 
EPS Diluted-$0.36-$0.36-$0.40-$0.44